Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Trump

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Medical and Pediatric Oncology|January 1, 1981
Doxorubicin, vincristine, and cis-diamminedichloroplatinum (II) therapy in patients with advanced breast cancerD L Trump, D S Ettinger, M D Abeloff
Cancer Treatment Reports|October 1, 1987
Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group StudyD L Trump, P Elson, H Brodovsky, et al.
Cancer|February 1, 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaR S Witte, P Elson, J Khandakar, et al.
Cancer Treatment Reports|September 1, 1983
Phase II study of amsacrine (AMSA) in previously treated patients with advanced transitional cell carcinoma of the urothelium: a National Bladder Cancer Collaborative Group A studyD L Trump, S Loening, S W Ahmed, et al.
Archives of Internal Medicine|March 1, 1982
CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapyD L Trump, S A Grossman, G Thompson, et al.
The American Journal of Medicine|May 1, 1989
Inadvertent administration of 480 mg/m2 of cisplatinJ H Schiller, J Rozental, K D Tutsch, et al.
American Journal of Clinical Oncology|December 1, 1989
A pilot study of short-course, high-dose cytosine arabinoside, etoposide, and cisplatin in refractory, aggressive-histology, non-Hodgkin's lymphomasJ H Schiller, P S Ritch, B Storer, et al.
The Journal of Urology|November 1, 1990
Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot studyR Dreicer, E M Messing, P J Loehrer, et al.
Cancer Research|December 15, 1994
Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508K K Chan, P S Hong, K Tutsch, et al.
Investigational New Drugs|April 1, 1992
Trimetrexate in advanced renal cell carcinoma. An ECOG phase II trialR S Witte, P Elson, G T Bryan, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Medical and Pediatric Oncology|January 1, 1981
Doxorubicin, vincristine, and cis-diamminedichloroplatinum (II) therapy in patients with advanced breast cancerD L Trump, D S Ettinger, M D Abeloff
Cancer Treatment Reports|October 1, 1987
Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group StudyD L Trump, P Elson, H Brodovsky, et al.
Cancer|February 1, 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaR S Witte, P Elson, J Khandakar, et al.
Cancer Treatment Reports|September 1, 1983
Phase II study of amsacrine (AMSA) in previously treated patients with advanced transitional cell carcinoma of the urothelium: a National Bladder Cancer Collaborative Group A studyD L Trump, S Loening, S W Ahmed, et al.
Archives of Internal Medicine|March 1, 1982
CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapyD L Trump, S A Grossman, G Thompson, et al.
The American Journal of Medicine|May 1, 1989
Inadvertent administration of 480 mg/m2 of cisplatinJ H Schiller, J Rozental, K D Tutsch, et al.
American Journal of Clinical Oncology|December 1, 1989
A pilot study of short-course, high-dose cytosine arabinoside, etoposide, and cisplatin in refractory, aggressive-histology, non-Hodgkin's lymphomasJ H Schiller, P S Ritch, B Storer, et al.
The Journal of Urology|November 1, 1990
Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot studyR Dreicer, E M Messing, P J Loehrer, et al.
Cancer Research|December 15, 1994
Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508K K Chan, P S Hong, K Tutsch, et al.
Investigational New Drugs|April 1, 1992
Trimetrexate in advanced renal cell carcinoma. An ECOG phase II trialR S Witte, P Elson, G T Bryan, et al.
Pageof 15